Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Won Oh

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Journal of Nanobiotechnology|April 10, 2026
Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injuryHochung Jang, Dongwon Shin, Byeongmin Park, et al.
Scientific Reports|December 9, 2021
Impact of acute kidney injury on long-term adverse outcomes in obstructive uropathyJihyun Yang, Bong Gyun Sun, Hyeon-Jin Min, et al.
The Korean Journal of Internal Medicine|October 17, 2022
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Electrolyte & Blood Pressure : E & BP|December 1, 2022
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of HyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Kidney Research and Clinical Practice|August 3, 2022
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Journal of Korean Neurosurgical Society|August 20, 2025
Clinical Practice Guideline for the Prehospital Stage in Acute Stroke : I. Use of Emergency Medical Services Assessment ToolsJae Sang Oh, Dongwook Seo, Jinwoo Jeong, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Journal of Nanobiotechnology|April 10, 2026
Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injuryHochung Jang, Dongwon Shin, Byeongmin Park, et al.
Scientific Reports|December 9, 2021
Impact of acute kidney injury on long-term adverse outcomes in obstructive uropathyJihyun Yang, Bong Gyun Sun, Hyeon-Jin Min, et al.
The Korean Journal of Internal Medicine|October 17, 2022
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Electrolyte & Blood Pressure : E & BP|December 1, 2022
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of HyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Kidney Research and Clinical Practice|August 3, 2022
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremiaYeonhee Lee, Kyung Don Yoo, Seon Ha Baek, et al.
Journal of Korean Neurosurgical Society|August 20, 2025
Clinical Practice Guideline for the Prehospital Stage in Acute Stroke : I. Use of Emergency Medical Services Assessment ToolsJae Sang Oh, Dongwook Seo, Jinwoo Jeong, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Pageof 12